DIVERGENT EFFECTS OF INSULIN ON INSULIN-LIKE GROWTH FACTOR-II GENE-EXPRESSION IN THE RAT HYPOTHALAMUS

被引:32
作者
LAUTERIO, TJ
ARAVICH, PF
ROTWEIN, P
机构
[1] EASTERN VIRGINIA MED SCH,DEPT INTERNAL MED & PHYSIOL,NORFOLK,VA 23501
[2] EASTERN VIRGINIA MED SCH,DEPT ANAT & CELL BIOL,NORFOLK,VA 23501
[3] WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,DIV METAB,ST LOUIS,MO 63110
[4] WASHINGTON UNIV,SCH MED,DEPT GENET,DIV METAB,ST LOUIS,MO 63110
关键词
D O I
10.1210/endo-126-1-392
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of peripheral insulin treatment on brain content and synthesis of insulin-like growth factor-II (IGF-II) was studied in acute and chronic conditions. After a 3- h hyperinsulinemic/euglycemic clamp, rats were killed, and brains were removed for IGF-II analysis. Insulin infusion elevated IGF-II concentrations in the dorsomedial hypothalamus (DMH) and suprachiasmatic nucleus, but decreased IGF-II in the paraventricular nucleus, lateral hypothalamus (LtH), and supraoptic nucleus compared to values in control animals. In separate parallel studies, the effects of 4 days of insulin injection (1 U insulin/rat, sc, twice daily) on brain IGF-II mRNA and peptide were determined. For RNA analysis the hypothalamus was divided into three regions (lateral, ventral, and dorsal). IGF-II mRNA content was shown to vary by an order of magnitude within the adult rat hypothalamus under control conditions, and there appeared to be a differential region-dependent response to insulin treatment. Relative abundance of IGF-II mRNA in control hypothalami was VH » cortex ≥ LtH > DMH. IGF-II mRNA content declined after insulin treatment in the VH, but rose in all other regions. Insulin increased IGF-II peptide content in the paraventricular nucleus, LtH, and VMH but decreased IGF-II in the DMH and suprachiasmatic nucleus. These results indicate that peripheral insulin status may be an important factor in the synthesis and secretion of IGF-II in the brain. © 1990 by The Endocrine Society.
引用
收藏
页码:392 / 398
页数:7
相关论文
共 42 条
  • [1] BASKIN DG, 1987, 69TH ANN M END SOC I, P42
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [4] COOK PS, 1986, AM J PHYSIOL, V14, pE624
  • [5] INHIBITION OF ACCESS OF BOUND SOMATOMEDIN TO MEMBRANE-RECEPTOR AND IMMUNOBINDING SITES - A COMPARISON OF RADIORECEPTOR AND RADIOIMMUNOASSAY OF SOMATOMEDIN IN NATIVE AND ACID-ETHANOL-EXTRACTED SERUM
    DAUGHADAY, WH
    MARIZ, IK
    BLETHEN, SL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (04) : 781 - 788
  • [6] DAUGHADAY WH, 1987, METHOD ENZYMOL, V146, P248
  • [7] DAUGHADAY WH, 1987, J LAB CLIN MED, V109, P355
  • [8] FRUNZIO R, 1986, J BIOL CHEM, V261, P7138
  • [9] GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84
  • [10] COORDINATE DEVELOPMENTAL REGULATION OF HIGH AND LOW-MOLECULAR-WEIGHT MESSENGER-RNAS FOR RAT INSULIN-LIKE GROWTH FACTOR-II
    GRAHAM, DE
    RECHLER, MM
    BROWN, AL
    FRUNZIO, R
    ROMANUS, JA
    BRUNI, CB
    WHITFIELD, HJ
    NISSLEY, SP
    SEELIG, S
    BERRY, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) : 4519 - 4523